Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Lead Market
Lead News
Lead Stocks

Astria Therapeutics Inc.

NASDAQ:ATXS:US

Featured Articles and Interviews

More Featured Articles and Inverviews

Press Releases

May 30, 2024

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

May 24, 2024

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

May 23, 2024

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

More Press Releases

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.

Go Deeper

AI Powered

Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks of 2025

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.